<p>miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin</p>Faping You, Xuchen Cao|Cancer Management and Research|2020Cited by 13
Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 TrialQingyuan Zhang, Qingshan Li, Yu Ren et al.|Cancer Research|2024Cited by 0